A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer

PHASE3CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

BioChaperone PDGF-BB

OTHER

Standard of Care

Trial Locations (32)

500 063

Mediciti Hospital, Hyderabad

400 016

SL Raheja Hospital, Mumbai

Unknown

M.V. Hospital for Diabetes (P) Ltd, Chennai

B.J. Medical College and Civil Hospital, Ahmedabad

Dr Jivraj Mehta Smarak Health Foundation, Ahmedabad

Sangini Hospital, Ahmedabad

V.S. General Hospital & Sml NHL Municipal Medical College Sheth, Ahmedabad

Rajiv Gandhi Centre for Diabetes and Endocrinology, Aligarh

Govt Medical College and Hospital, Chandigarh

Sri Ramachandra Medial Centre, Chennai

The Madras Diabetes Research Foundation, Chennai

The Madras Medical Mission, Chennai

Gandhi Medical College & Hospital, Hyderabad

Nizam's Institute of Medical Sciences, Hyderabad

Sumana Hospital, Hyderabad

Surakshaka diabetic Centre(P) Ltd, Hyderabad

SMS Medical College & Attached Hospital, Jaipur

ILS Hospital, Kolkata

IPGME & R and SSKM Hospital, Kolkata

Nightingale Hospital, Kolkata

Rabindranath Tagore International Insitute of cardiac Sciences, Kolkata

Fortis Hospital Phase, Mohali

Seth G.S. Medical College and K.E.M Hospital, Mumbai

Mysore Medical College & Research Institute, Mysore

Govt Medical college & Hospital Medical Square, Nagpur

Indira Gandhi Govt Medical College and Hospital, Nagpur

B.J. Govt. Medical College and Sassoon Hospital, Pune

Inamdar Multispeciality Hospital, Pune

Poona Hospital & Research Centre, Pune

Shree Giriraj Multispeciality Hospital, Rajkot

King Georges Hospital, Visakhapatnam

600 029

Dr V. Seshiah Diabetes Research Institute, Dr Balaji Diabetes Care centre, Chennai

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Virchow Group

INDUSTRY

lead

Adocia

INDUSTRY

NCT02236793 - A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer | Biotech Hunter | Biotech Hunter